HFEA comments on Lords regenerative medicine report
01 July 2013
We welcome the Lords Science and Technology Committee’s report into regenerative medicine.
The law requires that all research involving human embryos is licensed by the HFEA to ensure that it is ethical and that the interests of participants are protected.
We are working with the other regulators in the vital area of regenerative medicine to make it easier for researchers to find their way through the regulatory system. And we are keen to eliminate any unnecessary regulatory burdens through joint inspections and other initiatives.
We will be working with the Health Research Agency to address the recommendations made in this report.
Ends
Notes to editors
-
The HFEA is the independent regulator for IVF treatment and embryo research. Our role is to protect patients and the public interest, to drive improvement in the treatment and research sectors and to provide information to the public and policymakers about treatment and research.
- The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA’s principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), artificial insemination (AI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos.
- Read the Lords Science and Technology Committee's report into regenerative medicine.
For further information please contact the HFEA press office on 020 7291 8226 or email press.office@hfea.gov.uk / jay.stone@hfea.gov.uk
Page last updated: 01 July 2013